The ideas generated from the Early Detection of Sporadic Pancreatic Cancer Summit Conference led to the design of a Strategic Map for Innovation. This map is built on three components: formation of an international collaborative effort; design of an actionable strategic plan; and implementation of operational standards, research priorities, and first phase initiatives. Through the committed efforts of leading researchers and institutions, philanthropic partners, government agencies, and supportive business entities, this endeavor will lead to future changes within the field and consequently impact the survival rate of those diagnosed with pancreatic cancer.
“A collaborative investment in research and translation into clinical practice is the only way that we will advance this field. We must work together to design a new strategic map through the sharing of knowledge, technology, resources, and commitment,” said Vay Liang W. (Bill) Go, M.D., a member of the Kenner Family Research Fund Scientific Advisory Board. “The Early Detection of Sporadic Pancreatic Cancer Summit Conference was the first ever convening of an international body of experts to directly address the need for a new approach. I am confident that as a result of this summit we will develop an early detection protocol to help individuals who are diagnosed with this disease.”
“Early Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation—A White Paper” was published in Pancreas in May 2015 to report on the outcomes derived from the Early Detection of Sporadic Pancreatic Cancer Summit Conference.
